• CaSR Patient Support
    Number : 1800 431 231
  • CaSR Patient Support
    Email : enquiries@casr.org.au
  • CaSR Patient Support
    Address : PO Box 3322, BELCONNEN DC, ACT, 2617

Getting a Drug Included on the Pharmaceutical Benefits Scheme (PBS) in Australia

Getting a drug subsidised on the Pharmaceutical Benefits Scheme (PBS) in Australia is a complex process that involves multiple steps and stakeholders. The PBS is a government-funded scheme that provides affordable medicines to Australian residents. It operates as a form of insurance, where the government subsidises the cost of approved medications, making them more affordable for consumers.

The process of getting a drug subsidised on the PBS involves the following steps:

1. Drug Development: The drug development process can take many years, involving pre-clinical and clinical trials to test the safety and effectiveness of the drug. The pharmaceutical company that develops the drug will usually apply for a patent to protect their intellectual property.

2. Registration: Once the drug has been tested and approved by the Therapeutic Goods Administration (TGA), it can be registered and marketed in Australia. The TGA is the regulatory body responsible for approving the use of therapeutic goods in Australia.

3. Application to list on the PBS: The pharmaceutical company can then apply to have the drug listed on the PBS. This involves submitting an application to the Pharmaceutical Benefits Advisory Committee (PBAC), a group of medical experts, economists, and consumer representatives who assess the clinical and cost-effectiveness of the drug. The PBAC considers factors such as the drug’s clinical benefit, cost-effectiveness, and the burden of the disease on the community.

4. Negotiation: If the PBAC recommends the drug for listing on the PBS, the pharmaceutical company will negotiate a price with the government. The price must be affordable for the government and represent value for money for taxpayers.

5. Listing: Once a price has been agreed upon, the drug will be added to the PBS. The government subsidises the cost of the drug, making it more affordable for consumers. Patients who are eligible for the PBS will pay a co-payment, which is a small fee that contributes to the cost of the medication.

It’s worth noting that not all drugs are subsidised on the PBS, and some medications may be available only through private prescription or not at all in Australia. The process for getting a drug subsidised on the PBS can be lengthy and expensive, and not all drugs are approved for subsidy.

In conclusion, getting a drug subsidised on the PBS in Australia is a complex process that involves multiple steps and stakeholders. The process can take many years and involve significant costs for pharmaceutical companies. The PBAC plays a crucial role in assessing the clinical and cost-effectiveness of drugs, and the government negotiates with pharmaceutical companies to ensure that medicines are affordable for consumers and represent value for money for taxpayers.